Author

K. F. Herold

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

A. D. White· 1 shared B. L. Roth· 1 shared H. C. Hemmings· 1 shared J. H. Shrimp· 1 shared J. Inglese· 1 shared J. L. Dahlin· 1 shared O. S. Andersen· 1 shared P. Dranchak· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

A. D. White

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Nonspecific membrane bilayer perturbations by ivermectin underlie SARS-CoV-2 in vitro activity

R. T. Eastman, R. Rusinova, K. F. Herold, X.-P. Huang, P. Dranchak, T. C. Voss, S. Rana, J. H. Shrimp, A. D. White, H. C. Hemmings, B. L. Roth, J. Inglese, O. S. Andersen, J. L. Dahlin

This study shows ivermectin reduces SARS-CoV-2 viral burden in vitro but at concentrations that also cause cytotoxicity, suggesting its antiviral effect may be due to nonspecific membrane perturbation rather than specific antiviral activity.

bioRxiv · Oct 23, 2023 · PreprintPharmacology & Toxicology